Nicholas Hoffman & Company, Llc. Bristol Myers Squibb CO Transaction History
Nicholas Hoffman & Company, Llc.
- $2.48 Billion
- Q4 2024
A detailed history of Nicholas Hoffman & Company, Llc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Nicholas Hoffman & Company, Llc. holds 31,142 shares of BMY stock, worth $1.71 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
31,142
Previous 30,691
1.47%
Holding current value
$1.71 Million
Previous $1.59 Million
10.89%
% of portfolio
0.07%
Previous 0.07%
Shares
31 transactions
Others Institutions Holding BMY
# of Institutions
2,749Shares Held
1.57BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$10.4 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.72 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.28 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.23 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.32 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $117B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...